Sam Bankman-Fried needs more Adderall to focus during trial, say lawyers
Lawyers for the FTX founder have asked if he can take long-release ADHD medication, as he’s been unable to properly concentrate during his trial.
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
Lawyers for the FTX founder have asked if he can take long-release ADHD medication, as he’s been unable to properly concentrate during his trial.
Why this matters
This cryptocurrency story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on CointelegraphRelated market context
Bitcoin needs trillions to go parabolic again as ETF demand fades
Bitcoin’s next major rally may depend less on whether investors still believe in the asset than on whether enough large balance sh...
Vitalik Buterin Says Ethereum’s Next Major Upgrade Will Take Three to Four Years and Rival the Merge
Ethereum co-founder Vitalik Buterin says the network’s next major overhaul, an initiative researchers are calling “Lean Ethereum,”...
Tether's Former CIO Heathcote Plans to Sell Equity Stake
Richard Heathcote, who until earlier this year served as Tether Holdings SA's chief investment officer, is planning to sell a smal...
OpenAI offers the US government a 5% stake worth $42.6 billion, and crypto markets are already feeling the ripple effects
OpenAI's government stake offer may set a precedent for tech-regulation synergy, impacting market dynamics and future AI policy fr...
Former Tether investment chief seeks to sell 1% stake in USDT issuer
The sale could set a valuation benchmark for Tether, influencing future fundraising, regulatory scrutiny, and competitive dynamics...
Former Tether investment chief seeks to sell 1% stake in the stablecoin giant
The sale's valuation will reveal market sentiment on Tether's regulatory risks and growth, impacting confidence in stablecoin-rela...